John Boland

John Boland has extensive work experience in the biotechnology and pharmaceutical industry. John is currently working at Antag Therapeutics as the Vice President of Clinical Operations, a preclinical stage biotechnology company focused on metabolic and cardiovascular autonomic diseases. Prior to their current role, John worked at Avalo Therapeutics (formerly Cerecor) as the Vice President of Clinical Operations from November 2017 to September 2022. Before that, they worked at Atlantic Research Group as the Vice President of Product Development from January 2013 to October 2017. John also has experience working at Chelsea Therapeutics as a member of the Clinical Operations and Program Management team from April 2005 to January 2013, and at PRA Health Sciences in a role related to clinical operations from July 2001 to March 2005.

John Boland attended Virginia Military Institute from 1995 to 1999. No specific degree or field of study was mentioned.